Perioperative concerns and management of pressurised intraperitoneal aerosolised chemotherapy: Report of two cases
暂无分享,去创建一个
[1] C. Tempfer,et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy , 2016, World Journal of Surgical Oncology.
[2] Martha Polovich. Minimizing Occupational Exposure to Antineoplastic Agents , 2016, Journal of infusion nursing : the official publication of the Infusion Nurses Society.
[3] W. Solass,et al. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[4] W. Solass,et al. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis , 2015, Journal of Gastrointestinal Surgery.
[5] W. Solass,et al. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects , 2013, Annals of Surgical Oncology.
[6] A. Macrì,et al. Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia. , 2011, World journal of gastrointestinal oncology.
[7] R. Gill,et al. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity , 2011, Journal of surgical oncology.
[8] D. Alderson,et al. Systematic review of intraperitoneal chemotherapy for gastric cancer , 2011, The British journal of surgery.
[9] Michael F. Flessner,et al. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence , 2010, Nature Reviews Clinical Oncology.